EQ Stock Summary and Trading Ideas (Equillium | NASDAQ:EQ)

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Equillium trades on the NASDAQ stock market under the symbol EQ.

As of April 22, 2026, EQ stock price climbed to $2.33 with 736,435 million shares trading.

EQ has a beta of -1.58, meaning it tends to be less sensitive to market movements. EQ has a correlation of 0.02 to the broad based SPY ETF.

EQ has a market cap of $147.32 million. This is considered a Micro Cap stock.

In the last 3 years, EQ traded as high as $3.25 and as low as $.27.

The top ETF exchange traded funds that EQ belongs to (by Net Assets): VTI, VXF, AVSC, DFAS, DFMC.

EQ has outperformed the market in the last year with a price return of +385.5% while the SPY ETF gained +36.3%. EQ has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +97.5% and +29.4%, respectively, while the SPY returned +3.5% and +5.2%, respectively.

EQ support price is $2.00 and resistance is $2.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EQ shares will trade within this expected range on the day.